…

HealthyPlan n/a · Option n/aFit for a long SIP

Mirae Asset Gold ETF

Mirae Asset Mutual Fund Exchange Traded Funds (ETFs) - Gold ETF3.7 years

NAV: 135.4132; 30 Oct 2026
1Y: +15.8%; Trailing CAGR
AUM: ₹3,251.05 Cr; 30 Jun 2026
Volatility: High; 17.7% annualized

NAV path pending

Buying brief

Should you add this fund?

Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.

As of 30 Oct 2026

Stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

In three lines

Fits if · The fund beat the category median in 86% of rolling 3-year windows.
Fits if · Three-year return is above the category median.

Buy checklist

History depth
Watch
3.7 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -22.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
86% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.

Evidence supports a shortlist - confirm with peers before you buy elsewhere.

NAV

Path not in current snapshots

n/a

Returns

Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.

Trailing CAGR

Point-to-point, calendar-day annualized

1Y+15.8%
3Y+30.5%
5Yn/a
10Yn/a
SI+26.9%

SIP XIRR

Equal monthly instalments to latest NAV

1Y-6.7%
3Y+28.8%
5Yn/a
10Yn/a

Since inception: +26.9%; Calendar-day CAGR
Excess 1Y: +104.3%; Category median, same plan and option
3Y win rate: +86%; Windows beating the median
3Y percentile: 100; Vs comparable share classes
SIP 3Y XIRR: +28.8%; Simulated monthly SIP
Worst rolling 3Y: +30.5%; 170 daily-ending windows
Median rolling 3Y: +34.8%; Calendar-day CAGR
Positive rolling 5Y: n/a; 0 daily-ending windows

Drawdown

Peak to trough from a running NAV high, with the path and recovery episodes.

Max drawdown: -22.1%; Worst peak-to-trough
Current: -20.1%; Below last peak
Current spell: 274 days; Days below latest peak
Time below peak: +86%; NAV observations

Drawdown

Path not in current snapshots

n/a

Average recovery: 10 days; 48 recovered episodes
Longest recovery: 69 days; Trough to prior peak

29 Jan 2026 – open
Trough 23 Mar 2026 · not recovered
-22.1%
17 Oct 2025 – 12 Dec 2025
Trough 28 Oct 2025 · recovered in 45 days
-9.3%
21 May 2024 – 23 Sept 2024
Trough 26 Jul 2024 · recovered in 59 days
-8.0%
4 May 2023 – 28 Nov 2023
Trough 6 Oct 2023 · recovered in 53 days
-7.9%

Dimensions

0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.

Returns
100
Vs category
100
Consistency
71
Risk-adjusted
81
Drawdown
45
Mean
79

Decision

Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.

Healthy

Buying stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

Why this status

No material deterioration, cost shock, or persistent category underperformance in the current evidence set.

Supporting reads

The fund beat the category median in 86% of rolling 3-year windows.
Three-year return is above the category median.
Risk-adjusted return sits above the documented risk-free proxy.

No holdings or recent changes on file for this scheme yet.

Worth investigating

Same-category peers with enough history to inspect beside this fund - including tradeoffs.

All funds

HealthyPlan n/a · Option n/aFit for a long SIP

Mirae Asset Gold ETF

Mirae Asset Mutual Fund Exchange Traded Funds (ETFs) - Gold ETF3.7 years

NAV: 135.4132; 30 Oct 2026
1Y: +15.8%; Trailing CAGR
AUM: ₹3,251.05 Cr; 30 Jun 2026
Volatility: High; 17.7% annualized

Oct 2024 – Oct 2026

All funds

HealthyPlan n/a · Option n/aFit for a long SIP

Mirae Asset Gold ETF

Mirae Asset Mutual Fund Exchange Traded Funds (ETFs) - Gold ETF3.7 years

NAV: 135.4132; 30 Oct 2026
1Y: +15.8%; Trailing CAGR
AUM: ₹3,251.05 Cr; 30 Jun 2026
Volatility: High; 17.7% annualized

NAV path pending

Buying brief

Should you add this fund?

Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.

As of 30 Oct 2026

Stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

In three lines

Fits if · The fund beat the category median in 86% of rolling 3-year windows.
Fits if · Three-year return is above the category median.

Buy checklist

History depth
Watch
3.7 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -22.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
86% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.

Evidence supports a shortlist - confirm with peers before you buy elsewhere.

NAV

30 Oct 2026 · +15.8% over 1Y

135.4132

Oct 2025116.9153 – 169.3978Oct 2026

Returns

Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.

Trailing CAGR

Point-to-point, calendar-day annualized

1Y+15.8%
3Y+30.5%
5Yn/a
10Yn/a
SI+26.9%

SIP XIRR

Equal monthly instalments to latest NAV

1Y-6.7%
3Y+28.8%
5Yn/a
10Yn/a

Since inception: +26.9%; Calendar-day CAGR
Excess 1Y: +104.3%; Category median, same plan and option
3Y win rate: +86%; Windows beating the median
3Y percentile: 100; Vs comparable share classes
SIP 3Y XIRR: +28.8%; Simulated monthly SIP
Worst rolling 3Y: +30.5%; 170 daily-ending windows
Median rolling 3Y: +34.8%; Calendar-day CAGR
Positive rolling 5Y: n/a; 0 daily-ending windows

Drawdown

Peak to trough from a running NAV high, with the path and recovery episodes.

Max drawdown: -22.1%; Worst peak-to-trough
Current: -20.1%; Below last peak
Current spell: 274 days; Days below latest peak
Time below peak: +86%; NAV observations

Drawdown

30 Oct 2026

-20.1%

Feb 2023-22.1% – 0.0%Oct 2026

Average recovery: 10 days; 48 recovered episodes
Longest recovery: 69 days; Trough to prior peak

29 Jan 2026 – open
Trough 23 Mar 2026 · not recovered
-22.1%
17 Oct 2025 – 12 Dec 2025
Trough 28 Oct 2025 · recovered in 45 days
-9.3%
21 May 2024 – 23 Sept 2024
Trough 26 Jul 2024 · recovered in 59 days
-8.0%
4 May 2023 – 28 Nov 2023
Trough 6 Oct 2023 · recovered in 53 days
-7.9%

Dimensions

0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.

Returns
100
Vs category
100
Consistency
71
Risk-adjusted
81
Drawdown
45
Mean
79

Decision

Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.

Healthy

Buying stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

Why this status

No material deterioration, cost shock, or persistent category underperformance in the current evidence set.

Supporting reads

The fund beat the category median in 86% of rolling 3-year windows.
Three-year return is above the category median.
Risk-adjusted return sits above the documented risk-free proxy.

No holdings or recent changes on file for this scheme yet.

Buying brief

Should you add this fund?

Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.

As of 30 Oct 2026

Stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

In three lines

Fits if · The fund beat the category median in 86% of rolling 3-year windows.
Fits if · Three-year return is above the category median.

Buy checklist

History depth
Watch
3.7 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -22.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
86% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.

Evidence supports a shortlist - confirm with peers before you buy elsewhere.

NAV

Path not in current snapshots

n/a

Returns

Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.

Trailing CAGR

Point-to-point, calendar-day annualized

1Y+15.8%
3Y+30.5%
5Yn/a
10Yn/a
SI+26.9%

SIP XIRR

Equal monthly instalments to latest NAV

1Y-6.7%
3Y+28.8%
5Yn/a
10Yn/a

Since inception: +26.9%; Calendar-day CAGR
Excess 1Y: +104.3%; Category median, same plan and option
3Y win rate: +86%; Windows beating the median
3Y percentile: 100; Vs comparable share classes
SIP 3Y XIRR: +28.8%; Simulated monthly SIP
Worst rolling 3Y: +30.5%; 170 daily-ending windows
Median rolling 3Y: +34.8%; Calendar-day CAGR
Positive rolling 5Y: n/a; 0 daily-ending windows

Drawdown

Peak to trough from a running NAV high, with the path and recovery episodes.

Max drawdown: -22.1%; Worst peak-to-trough
Current: -20.1%; Below last peak
Current spell: 274 days; Days below latest peak
Time below peak: +86%; NAV observations

Drawdown

Path not in current snapshots

n/a

Average recovery: 10 days; 48 recovered episodes
Longest recovery: 69 days; Trough to prior peak

29 Jan 2026 – open
Trough 23 Mar 2026 · not recovered
-22.1%
17 Oct 2025 – 12 Dec 2025
Trough 28 Oct 2025 · recovered in 45 days
-9.3%
21 May 2024 – 23 Sept 2024
Trough 26 Jul 2024 · recovered in 59 days
-8.0%
4 May 2023 – 28 Nov 2023
Trough 6 Oct 2023 · recovered in 53 days
-7.9%

Dimensions

0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.

Returns
100
Vs category
100
Consistency
71
Risk-adjusted
81
Drawdown
45
Mean
79

Decision

Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.

Healthy

Buying stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

Why this status

No material deterioration, cost shock, or persistent category underperformance in the current evidence set.

Supporting reads

The fund beat the category median in 86% of rolling 3-year windows.
Three-year return is above the category median.
Risk-adjusted return sits above the documented risk-free proxy.

No holdings or recent changes on file for this scheme yet.

Worth investigating

Same-category peers with enough history to inspect beside this fund - including tradeoffs.

Buying brief

Should you add this fund?

Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.

As of 30 Oct 2026

Stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

In three lines

Fits if · The fund beat the category median in 86% of rolling 3-year windows.
Fits if · Three-year return is above the category median.

Buy checklist

History depth
Watch
3.7 years - usable, still building a track record.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
n/a
TER not on file yet.
Drawdown vs peers
Pass
Peak-to-trough -22.1%. Ask whether you can hold through a similar fall.
Vs category
Pass
86% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
n/a
Manager not listed.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
n/a
Holdings weights not on file for this scheme yet.

Evidence supports a shortlist - confirm with peers before you buy elsewhere.

NAV

30 Oct 2026 · +15.8% over 1Y

135.4132

Oct 2025116.9153 – 169.3978Oct 2026

Returns

Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.

Trailing CAGR

Point-to-point, calendar-day annualized

1Y+15.8%
3Y+30.5%
5Yn/a
10Yn/a
SI+26.9%

SIP XIRR

Equal monthly instalments to latest NAV

1Y-6.7%
3Y+28.8%
5Yn/a
10Yn/a

Since inception: +26.9%; Calendar-day CAGR
Excess 1Y: +104.3%; Category median, same plan and option
3Y win rate: +86%; Windows beating the median
3Y percentile: 100; Vs comparable share classes
SIP 3Y XIRR: +28.8%; Simulated monthly SIP
Worst rolling 3Y: +30.5%; 170 daily-ending windows
Median rolling 3Y: +34.8%; Calendar-day CAGR
Positive rolling 5Y: n/a; 0 daily-ending windows

Drawdown

Peak to trough from a running NAV high, with the path and recovery episodes.

Max drawdown: -22.1%; Worst peak-to-trough
Current: -20.1%; Below last peak
Current spell: 274 days; Days below latest peak
Time below peak: +86%; NAV observations

Drawdown

30 Oct 2026

-20.1%

Feb 2023-22.1% – 0.0%Oct 2026

Average recovery: 10 days; 48 recovered episodes
Longest recovery: 69 days; Trough to prior peak

29 Jan 2026 – open
Trough 23 Mar 2026 · not recovered
-22.1%
17 Oct 2025 – 12 Dec 2025
Trough 28 Oct 2025 · recovered in 45 days
-9.3%
21 May 2024 – 23 Sept 2024
Trough 26 Jul 2024 · recovered in 59 days
-8.0%
4 May 2023 – 28 Nov 2023
Trough 6 Oct 2023 · recovered in 53 days
-7.9%

Dimensions

0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.

Returns
100
Vs category
100
Consistency
71
Risk-adjusted
81
Drawdown
45
Mean
79

Decision

Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.

Healthy

Buying stance

Fit for a long SIP

Evidence supports keeping this on a shortlist for a multi-year equity SIP.

Why this status

No material deterioration, cost shock, or persistent category underperformance in the current evidence set.

Supporting reads

The fund beat the category median in 86% of rolling 3-year windows.
Three-year return is above the category median.
Risk-adjusted return sits above the documented risk-free proxy.

No holdings or recent changes on file for this scheme yet.

Mirae Asset Gold ETF

Should you add this fund?

Returns

Drawdown

Dimensions

Decision

Worth investigating

UTI - Gold Exchange Traded Fund

360 ONE Gold ETF

Mirae Asset Gold ETF

Mirae Asset Gold ETF

Should you add this fund?

Returns

Drawdown

Dimensions

Decision

Should you add this fund?

Returns

Drawdown

Dimensions

Decision

Worth investigating

UTI - Gold Exchange Traded Fund

360 ONE Gold ETF

Mirae Asset Gold ETF

Should you add this fund?

Returns

Drawdown

Dimensions

Decision